Effects and mechanism of recombinant human erythropoietin on the growth of human breast cancer MDA-MB-231 cells in nude mice

作者: Wen Jin , Zhiwu Lin , Xiaorong Zhang , Lingying Kong , Li Yang

DOI: 10.1016/J.PRP.2015.04.006

关键词: Internal medicineMicrovesselCancer researchAngiogenesisErythropoietinImmunohistochemistryCancerAntibodyApoptosisErythropoietin receptorEndocrinologyMedicine

摘要: This study aimed to explore the effects of recombinant human erythropoietin (rhEPO) on growth breast cancer MDA-MB-231 cells in nude mice, and investigate its functions regulating tumor growth, angiogenesis apoptosis. A tumor-bearing mice model was established by subcutaneous injection cells. Two weeks later, were randomly divided into four groups (n=6 for each group): negative control group, rhEPO EPO antibody group EPO+EPO group. Drugs administered corresponding once every 3 days five times. The size weight tumors measured after sacrificed cervical dislocation. expression levels EPO/EPOR, TNF-α, IL-10, Bcl-2 tissues determined using RT-PCR Western blot. microvessel density (MVD) VEGF detected immunohistochemistry. TUNEL assay used determine apoptosis tumors. Results show that significantly promoted (P<0.05). Compared with EPO, EPOR, VEGF, as well MVD values, elevated However, apoptotic index reduced ability promote may be associated promoting formation inhibiting cell

参考文章(29)
Błazelonis A, Danikiewicz A, Braczkowski R, Muc-Wierzgon M, Romanawsky W, Zubelewicz B, Decrease of erythropoietin level by human recombinant tumour necrosis factor alpha (hrec TNFalpha) in patients with advanced cancer. Journal of Biological Regulators and Homeostatic Agents. ,vol. 15, pp. 366- 369 ,(2001)
Jolanta Szenajch, Gabriel Wcislo, Jee-Yeong Jeong, Cezary Szczylik, Laurie Feldman, The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells From clinic to bench - a critical review. Biochimica et Biophysica Acta. ,vol. 1806, pp. 82- 95 ,(2010) , 10.1016/J.BBCAN.2010.04.002
Francesco Locatelli, Andrea Cavalli, Lucia Del Vecchio, Benedetta Tucci, Chronic kidney disease-associated anemia: new remedies. Current opinion in investigational drugs. ,vol. 11, pp. 1030- 1038 ,(2010)
Carla Cerami Hand, Michael Brines, Promises and Pitfalls in Erythopoietin-Mediated Tissue Protection Journal of Investigative Medicine. ,vol. 59, pp. 1073- 1082 ,(2011) , 10.2310/JIM.0B013E3181ED30BF
Benjamin D. Hedley, Jenny E. Chu, D. George Ormond, Michel S. Beausoleil, Alexandra Boasie, Alison L. Allan, Anargyros Xenocostas, Recombinant Human Erythropoietin in Combination with Chemotherapy Increases Breast Cancer Metastasis in Preclinical Mouse Models Clinical Cancer Research. ,vol. 17, pp. 6151- 6162 ,(2011) , 10.1158/1078-0432.CCR-10-3298
Arthur Sytkowski, Location and the functionality of erythropoietin receptor(s) in A2780 cells Oncology Reports. ,vol. 28, pp. 141- 146 ,(2012) , 10.3892/OR.2012.1795
Mario Dicato, Laurent Plawny, Erythropoietin in cancer patients: pros and cons. Current Opinion in Oncology. ,vol. 22, pp. 307- 311 ,(2010) , 10.1097/CCO.0B013E32833AA9DE
JINSHENG YANG, ZHENG XIAO, TAO LI, XUANMIN GU, BO FAN, Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis International Journal of Oncology. ,vol. 40, pp. 1230- 1237 ,(2012) , 10.3892/IJO.2011.1261
Magdalena Laugsch, Eric Metzen, Tanja Svensson, Reinhard Depping, Wolfgang Jelkmann, Lack of functional erythropoietin receptors of cancer cell lines. International Journal of Cancer. ,vol. 122, pp. 1005- 1011 ,(2007) , 10.1002/IJC.23201
M. Schmeding, U.P. Neumann, S. Boas-Knoop, A. Spinelli, P. Neuhaus, Erythropoietin reduces ischemia-reperfusion injury in the rat liver. European Surgical Research. ,vol. 39, pp. 189- 197 ,(2007) , 10.1159/000101009